Company / Gross Profit
Niagen Bioscience, Inc. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$83.2M
FY2025
5-year range
$35.3M / $83.2M
FY2021-FY2025
Trend
+63.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 5 consecutive years, from $26M in FY2020 to $83M in FY2025.
Based on SEC 10-K filings.
$83M in FY2025 with a 5-year CAGR of +26.4%.
Improved from $43M to $83M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +26.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s gross profit has grown for 5 consecutive years.
- 5-year CAGR of +26.4%, indicating consistent growth.
- In FY2025, gross profit increased 63.8% year-over-year.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.2M | +63.8% |
| FY2024 | $50.8M | +18.7% |
| FY2023 | $42.8M | +3.2% |
| FY2022 | $41.5M | +17.6% |
| FY2021 | $35.3M | +36.9% |
| FY2020 | $25.8M | +0.0% |
| FY2019 | $25.8M | +146.0% |
| FY2018 | $10.5M | +0.0% |
| FY2017 | $10.5M | +0.8% |
| FY2016 | $10.4M | +37.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026